MGMT and cancer: In a study by Majchrzak-Celińska et al., methylation profiles of biomarkers—MGMT, RASSF1A, p15INK4B, and p14ARF—in cancer patient’s serum were found to match the methylation profiles in paired tumor samples in most cases [77].